@article{70da3bda7e8a4a89a96775073e09b7af,
title = "Allografts in joint reconstruction: ESSKA making a difference",
author = "Tim Spalding and Peter Verdonk and \{de Girolamo\}, Laura and Romain Seil and David Dejour",
note = "Funding Information: Allograft technologies might be more expensive, and their sustainability needs to be justified in the world of rationing healthcare. Each country in Europe and worldwide will have their own level of value for a treatment but the cornerstone for any approval to use such clinically valuable treatments is accurate cost-effectiveness information, and this is the basis of the initiative. The cost-effectiveness Health Technology Appraisal (HTA) was funded through the ESSKA Foundation.",
year = "2019",
month = jun,
day = "1",
doi = "10.1007/s00167-019-05514-2",
language = "English",
volume = "27",
pages = "1701--1703",
journal = "Knee Surgery, Sports Traumatology, Arthroscopy",
issn = "0942-2056",
publisher = "John Wiley and Sons Inc",
number = "6",
}